Ajanta Pharma may raise Rs 2,000 crore to acquire controlling stake in Restaurant Brands Asia

Ajanta Pharma's promoters are exploring financing options of up to ₹2,000 crore to fund the acquisition of a controlling stake in Restaurant Brands Asia, the India and Indonesia franchisee of Burger King. Barclays and Standard Chartered are among banks that have been sounded out for the funding, though talks remain at a preliminary stage. The financing structure is still being finalised and no lender has been formally appointed.